Potential Risks and Considerations Like any prescription-based weight loss program, there are important considerations to review before starting
Retatrutide and High Blood Pressure: Evidence, Cautions, and UK Guidance Retatrutide and high blood pressure is an emerging area of clinical interest, as this investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously has shown modest blood pressure reductions in early Phase 2 trials
Calibrate is a year-long, structured weight-loss program that pairs GLP-1 medication like Ozempic, Wegovy, or Mounjaro with personalized coaching and a science-backed lifestyle curriculum
Gramlich, for his part, surrendered his pharmacy license in 2025 and, according to public reporting and board records, agreed to wait at least three years before seeking reinstatement and to reimburse nearly $60,000 to cover the pharmacy boards investigation costs
Actual stability depends on peptide chemistry, concentration, storage temperature, and handling quality